1-butoxy-4-ethoxybenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-butoxy-4-ethoxybenzene
• 英文别名: 1-butoxy-4-ethoxy benzene；1-Butyloxy-4-ethoxybenzene
• 化学式: C₁₂H₁₈O₂
• 分子量: 194.274
• InChiKey: HPURGUWAHVUCHJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-溴苯乙醚 、 sodium butanolate 在 甲酸丁酯 、 lithium chloride 、 copper(I) bromide 作用下， 以 正丁醇 为溶剂， 反应 7.0h， 以96%的产率得到1-butoxy-4-ethoxybenzene
  参考文献：
  名称：

  未活化芳基溴的实用无配体铜催化短链烷氧基化

  摘要：

  已开发出一种有效且实用的未活化芳基溴化物的短链烷氧基化，特别关注反应的适用性。醇钠用作亲核试剂，相应的醇用作溶剂。该反应既不需要贵金属也不需要有机配体。它使用由溴化铜 (I) 作为催化剂、相应的甲酸烷基酯作为无污染助催化剂和氯化锂作为添加剂组成的催化体系。广泛的底物和测试用例突出了该方法的综合效用。考虑到原料的商业可及性和可负担性，该协议显示出作为可持续制备芳基烷基醚的新替代方案的希望。

  DOI：

  10.1002/ejoc.201500500

文献信息

• The use of anion exchange resins for the synthesis of combinatorial libraries containing aryl and heteroaryl ethers
  作者：John J. Parlow

  DOI：10.1016/0040-4039(96)01113-6

  日期：1996.7

  mixture of ten aryloxides and heteroaryloxides. The feasibility of generating combinatorial libraries containing aryl and heteroaryl ethers was demonstrated by reacting the resin's with a single electrophile (n-butyl bromide) to afford mixtures of ether products. The advantages of using quaternary ammonium exchange resins over solution phase chemistry to prepare this library are discussed.

  季铵交换树脂（的Amberlite ® IRA-900）中制备每个含有10芳氧基和heteroaryloxides的混合物。通过使树脂与单一的亲电子试剂（正丁基溴化物）反应以提供醚产物的混合物，证明了生成包含芳基和杂芳基醚的组合库的可行性。讨论了使用季铵交换树脂优于溶液相化学制备该文库的优点。
• METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar
  申请人：PLETTNER ERIKA

  公开号：US20130045178A1

  公开（公告）日：2013-02-21

  The invention provides in part dialkoxybenzene and eugenol compounds for controlling infestation by a Lymantria dispar , and methods thereof. The compounds include a compound of Formula I: where R1 may be methyl, ethyl, propyl, n-butyl, isopentyl (3-methylbutyl) or allyl; R2 may be at positions 2, 3 or 4 and may be H, methyl, ethyl, propyl, n-butyl, isopentyl (3-methylbutyl) or allyl; and R3 may be optionally present at positions 2, 3 and 4, and is allyl; with the provisos that when R2 is at position 2, R3 if present is at position 3, or when R2 is at position 3, R3 if present is at positions 2 or 4, or when R2 is at position 4, R3 if present is at position 2; or of Formula II: where R1 may be methyl, ethyl, propyl, n-butyl, isopentyl (3-methylbutyl) or allyl; or mixtures thereof.
• [EN] THERAPEUTIC AGENTS AND METHODS OF TREATMENT<br/>[FR] AGENTS THÉRAPEUTIQUES ET MÉTHODES DE TRAITEMENT
  申请人：UNIV FLORIDA

  公开号：WO2020163823A2

  公开（公告）日：2020-08-13

  The invention is directed towards compounds (e.g., Formula (I)), their mechanism of action, and methods of modulating proliferation activity, and methods of treating diseases and disorders using the compounds described herein (e.g., Formula (I)).